The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Publication date: Available online 1 November 2018Source: The Lancet PsychiatryAuthor(s): Louisa Degenhardt, Fiona Charlson, Alize Ferrari, Damian Santomauro, Holly Erskine, Ana Mantilla-Herrara, Harvey Whiteford, Janni Leung, Mohsen Naghavi, Max Griswold, Jürgen Rehm, Wayne Hall, Benn Sartorius, James Scott, Stein Emil Vollset, Ann Kristin Knudsen, Josep Maria Haro, George Patton, Jacek Kopec, Deborah Carvalho MaltaSummaryBackgroundAlcohol and drug use can have negative consequences on the health, economy, productivity, and social aspects of communities. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to calculate global and regional estimates of the prevalence of alcohol, amphetamine, cannabis, cocaine, and opioid dependence, and to estimate global disease burden attributable to alcohol and drug use between 1990 and 2016, and for 195 countries and territories within 21 regions, and within seven super-regions. We also aimed to examine the association between disease burden and Socio-demographic Index (SDI) quintiles.MethodsWe searched PubMed, EMBASE, and PsycINFO databases for original epidemiological studies on alcohol and drug use published between Jan 1, 1980, and Sept 7, 2016, with out language restrictions, and used DisMod-MR 2.1, a Bayesian meta-regression tool, to estimate population-level prevalence of substance use disorders. We combined these estimates with disability weights to calculate years of life lived wit...
Source: The Lancet Psychiatry - Category: Psychiatry Source Type: research